HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.

[1]  Zongfu Pan,et al.  The differences of regulatory networks between papillary and anaplastic thyroid carcinoma: an integrative transcriptomics study , 2020, Cancer biology & therapy.

[2]  Jianliu Wang,et al.  Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis , 2020, International journal of biological sciences.

[3]  R. Weinberg,et al.  Emerging Mechanisms by which EMT Programs Control Stemness. , 2020, Trends in cancer.

[4]  T. Higashiyama,et al.  Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma , 2020, Cancers.

[5]  S. Romano,et al.  Cell Stemness, Epithelial-to-Mesenchymal Transition, and Immunoevasion: Intertwined Aspects in Cancer Metastasis. , 2020, Seminars in cancer biology.

[6]  J. Zhao,et al.  STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway , 2019, Cancer science.

[7]  M. Hedayati,et al.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review , 2019, Endocrine.

[8]  Gang Wang,et al.  CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis. , 2019, Cancer letters.

[9]  Zongfu Pan,et al.  Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma , 2019, BioMed research international.

[10]  Zhihua Liu,et al.  USP26 promotes esophageal squamous cell carcinoma metastasis through stabilizing Snail. , 2019, Cancer letters.

[11]  Ping Zheng,et al.  Hypoxia induces actin cytoskeleton remodeling by regulating the binding of CAPZA1 to F-actin via PIP2 to drive EMT in hepatocellular carcinoma. , 2019, Cancer letters.

[12]  M. Takeichi,et al.  Loss of CAMSAP3 promotes EMT via the modification of microtubule–Akt machinery , 2018, Journal of Cell Science.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  Qiong Shen,et al.  KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway , 2018, Oncogene.

[15]  J. Liou,et al.  Novel microtubule inhibitor MPT0B098 inhibits hypoxia-induced epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma , 2018, Journal of Biomedical Science.

[16]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[17]  Bingfei Xu,et al.  HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity , 2017, Molecular Cancer.

[18]  J. Fagin,et al.  Biologic and Clinical Perspectives on Thyroid Cancer. , 2016, The New England journal of medicine.

[19]  L. Li,et al.  Junctophilin 3 expresses in pancreatic beta cells and is required for glucose-stimulated insulin secretion , 2016, Cell Death and Disease.

[20]  T. Liang,et al.  Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition* , 2016, The Journal of Biological Chemistry.

[21]  K. Korkmaz,et al.  HN1 Negatively Influences the β‐Catenin/E‐Cadherin Interaction, and Contributes to Migration in Prostate Cells , 2015, Journal of cellular biochemistry.

[22]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[23]  Angélica Figueroa,et al.  Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells , 2014, BMC Cancer.

[24]  N. Grigorieff,et al.  Molecular Basis for Age-Dependent Microtubule Acetylation by Tubulin Acetyltransferase , 2014, Cell.

[25]  T. Yoshida,et al.  Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states , 2014, British Journal of Cancer.

[26]  S. Imbeaud,et al.  A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. , 2013, Gastroenterology.

[27]  M. Dewaele,et al.  mRNA Expression in Papillary and Anaplastic Thyroid Carcinoma: Molecular Anatomy of a Killing Switch , 2012, PloS one.

[28]  V. Detours,et al.  A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic , 2012, Oncogene.

[29]  K. Korkmaz,et al.  Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its knockdown results in deregulated G2/M transition in prostate cells. , 2011, DNA and cell biology.

[30]  G. Shaw,et al.  Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest. , 2009, Differentiation; research in biological diversity.

[31]  Gerry Shaw,et al.  Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas , 2009, Pathology & Oncology Research.

[32]  S. Miyamoto,et al.  Biologic significance of receptor‐binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer , 2007, Cancer.

[33]  F. Tokunaga,et al.  Induced expression of hematopoietic- and neurologic-expressed sequence 1 in retinal pigment epithelial cells during newt retina regeneration. , 2006, Experimental eye research.

[34]  S. Fouix,et al.  Jupiter, a new Drosophila protein associated with microtubules. , 2006, Cell motility and the cytoskeleton.

[35]  H. Baker,et al.  The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration‐associated gene , 2005, Journal of neuroscience research.

[36]  Robert C. Bast,et al.  Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis , 2004, Clinical Cancer Research.

[37]  Long Yu,et al.  Cloning, expression and subcellular localization of HN1 and HN1L genes, as well as characterization of their orthologs, defining an evolutionarily conserved gene family. , 2004, Gene.